This is a preview of subscription content, log in via an institution to check access.
Notes
Delivering on the Potential of Biosimilar Medicines: The Role of Functioning Competitive Markets
Reference
Constantino T, et al. IMS Health: Surge in Biosimilars to Drive Significant Change in Health System Costs, Patient Access and Competition by 2020. Internet Document : 28 Mar 2016. Available from: URL: http://www.imshealth.com/en/thought-leadership/ims-institute/news-and-press/ims-health-surge-in-biosimilars-to-drive-change-in-health-system-costs
Rights and permissions
About this article
Cite this article
Biosimilars set to drive significant savings in healthcare systems. PharmacoEcon Outcomes News 750, 3 (2016). https://doi.org/10.1007/s40274-016-2926-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2926-3